je.st
news
Tag: patients
First TomoTherapy System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients
2015-02-09 11:31:46| Industrial Newsroom - All News for Today
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif. Accuray Incorporated (Nasdaq: ARAY) announced today that the first TomoTherapy System in Latin America dedicated solely to the treatment of breast cancer is now operational at...
Tags: system
care
america
cancer
Enanta Announces 95 percent SVR12 Rate In AbbVie's Phase 3 Study Of All-Oral Treatment For Hepatitis C Virus In Japanese Patients
2015-02-04 07:01:33| drugdiscoveryonline Home Page
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, recently announced topline Phase 3 results from the GIFT-1 study, AbbVie’s investigational, all-oral, ribavirin-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir (OBT/PTV/r) in patients with genotype 1b (GT1b) chronic hepatitis C virus (HCV) infection in Japan
RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device
2015-02-02 14:32:07| Industrial Machines - Topix.net
RTI Health Solutions , a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity. In addition to clinical study results, FDA considered the study results to quantify patients' preferences for benefits and acceptability of risks of various obesity devices.
Tags: study
partner
device
approval
QIAGEN Introduces QuantiFERON Monitor for Tracking Immune Function in Solid Organ Transplant Patients and for Research Into other Applications
2015-02-02 11:32:10| Industrial Newsroom - All News for Today
HILDEN, Germany, and GERMANTOWN, Maryland, - QuantiFERON Monitor (QFM) launches in Europe for monitoring immune function - Target markets include transplant patients and research in managing immune modulation and suppression - Novel diagnostic with significant potential to expand clinical utility and to address...
Tags: other
into
research
function
Washington state Medicaid, public employee patients see changes to hepatitis C treatment
2015-01-01 01:04:37| Biotech - Topix.net
More people in Washington state who are on Medicaid or who get their health coverage through the Public Employee Benefit Board program will have access to revolutionary hepatitis C treatments. As new hepatitis C treatments came to market over the past year, the Washington State Health Care Authority has tweaked its policy for providing those treatments to thousands of patients.
Tags: state
public
washington
treatment
Sites : [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] next »